New GDPR legislation is pushing pharmaceutical solution providers to revolutionize their marketing practices.
The final guidance from the FDA confirms quality management systems continue to be critical to the production of Software as a Medical Device (SaaMDs).
Around 90 per cent of the world’s data was generated in the past two years alone, presenting the biomedical sector with a significant challenge, said Professor Jackie Hunter
As pharma continues its journey towards obtaining the optimal data lifecycle, four industry experts contemplate what the path ahead looks like for pharma innovation and the implementation of GDPR.
Ernan Roman explores recent research showing that pharma and biotech companies make expensive mistakes by neglecting the power and necessity of customer experience strategies.
Delving into the common misconceptions surrounding value based pricing and value based payment in pharma.
George clinical discusses how wearables are enhancing clinical trials, with one smart watch app tripling enrollment rates for a research project.
Sameer Thapar, Global Pharmacovigilance Operations & Compliance, Rutgers University discusses the future of pharmacovigilance.
Michael Popov Director Researcher at Prime States Quantum Lab looks at how artificial intelligence is being applied at the forefront of medical research, including the likes of oncology.
Andrew love explores how the ‘most significant changes to medical device legislation in decades’ will impact their supply and implementation.